BioCentury
ARTICLE | Clinical News

Starpharma preclinical data

December 8, 2008 8:00 AM UTC

In vitro, SPL7013 inhibited HPV types 16, 18 and 31, which are associated with cervical cancer, and HPV types 6 and 11, which are associated with genital warts. SPL7013 is the active ingredient in Viv...